Our department is responsible for the planning, implementation and running of clinical studies within various therapeutic areas where pathogenic IgG’s drive the disease. The main focus is enabling kidney transplantation in highly sensitized patients, but we are also studying the treatment of Acute Antibody Mediated Rejection in kidney transplant patients. In addition, we run studies within the autoimmune conditions; Guillain-Barré syndrome and Anti–glomerular basement membrane (anti-GBM). We are an experienced team working with clinical research in serious and complex diseases together with various internal and external stakeholders.
Workplace & Culture
We are based in Lund, Sweden, and we pride ourselves on providing a supportive team structure and offering numerous opportunities for staff from different departments to work together, sharing knowledge and learning from each other.
Our future as a dynamic organisation is largely dependent on the knowledge, creativity and skills of our employees. We have an informal and flexible work environment, providing numerous opportunities for professional and personal development.
